Ep49: The Evolution of Digital Therapeutics & the Future of the Industry

In this episode we kick off the next chapter of the DTx podcast. We heard you loud and clear - this industry is here to stay and therefore we are moving away from Seasons and going Evergreen - so what does that mean for you? It means we will continue bringing you deep conversations and knowledge from trailblazers, policy makers, associations and of course patients and health consumers. Chandana Fitzgerald, CEO of HealthXL has agreed to continue being my partner on this podcast asking the tough questions and dive into a short recap of last year’s DTx news but also what we are seeing as some of the key trends emerging into 2023 and beyond.   In this episode, we cover: How digital therapeutics have evolved and the future of DTx The Access to Prescription Digital Therapeutics Act of 2022  Digital Therapeutic Alliance approaches to evidence generation and upcoming conferences  Scaling DTx Pharmacy Benefits Management systems Navigating Sick care vs Healthcare And much more! Guest Links and Resources: Chandana Fitzgerald on LinkedIn Visit HealthXL Host Links: Eugene Borukhovich: Twitter | LinkedIn Chandana Fitzgerald, MD: Twitter | LinkedIn YourCoach.health: Website | Twitter Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Digital Health Today and the DTx Podcast would not be possible without the support of leading organizations. Thank you to: • Presenting Partner: Amalgam Rx • Sponsors: Akili • Big Health • Click Therapeutics • Lindus Health Follow Digital Health Today: Browse Episodes • Twitter • LinkedIn • Facebook • Instagram Follow Health Podcast Network: Browse Shows • LinkedIn • Twitter • Facebook • Instagram